Literature DB >> 1604709

Drugs of abuse: behavioural principles, methods and terms.

I Stolerman1.   

Abstract

Current understanding of drug abuse has been greatly influenced by the emphasis on drug-seeking behaviour as the common element. The three main attributes of drugs that maintain, direct and regulate drug-seeking behaviour are their positively reinforcing and discriminative and aversive stimulus properties. Each process may be analysed in terms of underlying behavioural and neural mechanisms that are mutually complementary and interactive. Environmental stimuli conditioned to the effects of the drugs also play a key role in eliciting and maintaining drug-seeking behaviour. Both the behavioural and the neural mechanisms are subject to modulating variables such as social, environmental and genetic factors, including the previous behavioural and pharmacological history of the individual. Thus, the behavioural approach to addiction does not preclude important roles for other factors, but rather seeks to integrate them into a comprehensive theoretical framework strongly linked to empirical data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604709     DOI: 10.1016/0165-6147(92)90059-f

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  46 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

2.  Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  A history of morphine-induced taste aversion learning fails to affect morphine-induced place preference conditioning in rats.

Authors:  Heather E King; Anthony L Riley
Journal:  Learn Behav       Date:  2013-12       Impact factor: 1.986

4.  The effects of repeated corticosterone exposure on the interoceptive effects of alcohol in rats.

Authors:  Joyce Besheer; Kristen R Fisher; Julie J M Grondin; Reginald Cannady; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2011-10-21       Impact factor: 4.530

5.  The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice.

Authors:  Clyde W Hodge; Michael F Miles; Amanda C Sharko; Rebekah A Stevenson; Jennie R Hillmann; Veronique Lepoutre; Joyce Besheer; Jason P Schroeder
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

6.  Activation of group II metabotropic glutamate receptors inhibits the discriminative stimulus effects of alcohol via selective activity within the amygdala.

Authors:  Reginald Cannady; Julie J M Grondin; Kristen R Fisher; Clyde W Hodge; Joyce Besheer
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

Review 7.  Drug abstinence: exploring animal models and behavioral treatment strategies.

Authors:  Joshua A Peck; Robert Ranaldi
Journal:  Psychopharmacology (Berl)       Date:  2014-03-16       Impact factor: 4.530

8.  Voluntary consumption of morphine in 15 inbred mouse strains.

Authors:  J K Belknap; J C Crabbe; J Riggan; L A O'Toole
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice.

Authors:  E Del Pozo; M Barrios; J M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

Review 10.  The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Authors:  Sunila G Nair; Tristan Adams-Deutsch; David H Epstein; Yavin Shaham
Journal:  Prog Neurobiol       Date:  2009-06-02       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.